STAT3 and hepatocellular carcinoma: Consistently, evidences have suggested that STAT3 activation is associated with HCC development, including cell invasion and angiogenesis, and STAT3 inhibitor S3I-201 blocks the malignant biological behaviors in HCC(Yan et al. 2017; Tu et al. 2020).